Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Evaxion A/S - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
EVAX
Nasdaq
2836
evaxion.ai
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Evaxion A/S
European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading
- May 13th, 2026 9:12 am
Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress
- May 12th, 2026 7:30 am
European Equities Traded in the US as American Depositary Receipts Rise Friday
- May 8th, 2026 9:10 am
Evaxion (EVAX) Q1 2026 Earnings Transcript
- May 7th, 2026 1:42 pm
Evaxion announces business update and first quarter 2026 financial results
- May 7th, 2026 5:30 am
Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026
- May 4th, 2026 6:00 am
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer
- Apr 27th, 2026 6:00 am
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
- Apr 24th, 2026 9:23 am
European Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading
- Apr 22nd, 2026 9:13 am
European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading
- Apr 21st, 2026 9:14 am
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
- Apr 17th, 2026 1:10 pm
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
- Apr 17th, 2026 1:00 pm
Evaxion concludes Annual General Meeting
- Apr 16th, 2026 9:30 am
European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading
- Apr 16th, 2026 9:05 am
European Equities Traded in the US as ADRs Rise in Tuesday Trading
- Apr 14th, 2026 9:05 am
European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading
- Apr 13th, 2026 9:04 am
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
- Apr 9th, 2026 9:14 am
European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading
- Apr 8th, 2026 9:03 am
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
- Apr 7th, 2026 6:00 am
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
- Mar 31st, 2026 9:22 am
Scroll